Remedium Research Tirzepatide Compounds
Welcome to the Remedium Research Tirzepatide catalog. We supply high-purity dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonists engineered specifically for advanced laboratory research and comparative metabolic studies across the UK.
Featured Tirzepatide Formulations
Remedium Research Tirzepatide 30mg Pen
Our flagship dual-agonist formulation, calibrated for precision volumetric control and consistent compound delivery in multi-phase research studies.
Understanding Dual GIP/GLP-1 Receptor Affinity
Tirzepatide is a synthetic peptide designed to target two primary metabolic receptor pathways simultaneously:
-
GIP Receptor Activation: Investigates lipid metabolism, adipose tissue energy handling, and synergistic metabolic signaling.
-
GLP-1 Receptor Activation: Evaluates glucose-dependent insulin secretion pathways and central signaling mechanisms related to satiety and metabolic rate.
Analytical Verification & Quality Control
Every lot of Remedium Research Tirzepatide undergoes comprehensive third-party batch verification. We provide downloadable Certificates of Analysis (COA) for all products, confirming high purity standards via HPLC and Mass Spectrometry.
